Kim Chapman M.D., Ph.D., FAAP, FABIM, FACMG 

Board Member and Medical Advisor

Dr. Kimberly Chapman is a full professor of Pediatrics at USC and Children’s Hospital, Los Angeles. She specializes in caring for individuals of all ages with defects of methylation, homocysteine, and propionate metabolism. 

Dr. Chapman graduated Summa Cum Laude with a Bachelor of Science in Chemistry and a Bachelor of Arts in Biology from Saint Louis University (St. Louis, MO, US).  She then earned a Medical Degree and Doctor of Philosophy from the University of Nebraska (US).   Then, she completed internships and residencies in internal medicine and pediatrics at the University of Pittsburgh Health Sciences Center. Finally, she completed a residency and fellowship in Clinical Genetics and Biochemical Genetics at the Children’s Hospital of Philadelphia.  Dr. Chapman is US board-certified in Pediatrics, Internal Medicine, Clinical Genetics, and Clinical Biochemical Genetics. 

She currently divides her time between clinical responsibilities, clinical research, including several patient registries and other clinical trials, and a basic science laboratory that studies the Propionate pathway and Krebs cycle. She firmly believes that clinical care informs bench research and research enhances clinical care. Thus, with collaborators, she is exploring and designing novel therapeutics for a number of metabolic disorders.